Farmers National Banc Corp has released its financial results for the third quarter of 2026, revealing significant growth in both assets and loans. This update is crucial as it reflects the bank's ability to navigate the competitive landscape of state commercial banking.
The filing, dated November 6, 2026, provides insights into the company's performance for the quarter ending September 30, 2026. The results indicate that Farmers National Banc Corp is not only maintaining but also expanding its market presence amid ongoing economic fluctuations.
Background
Farmers National Banc Corp, incorporated in Ohio, operates primarily in the state commercial banking sector (SIC: 6022). The company trades on the Nasdaq under the ticker symbol FMNB. Recent filings include a 10-Q on November 6, 2026, and a Schedule 13G on October 30, 2026.
What the Filing Says
Details from the filing indicate that the bank's available-for-sale debt securities have increased to approximately $1.68 billion as of September 30, 2026, up from $1.53 billion at the end of 2025. Additionally, the bank reported a significant rise in common stock shares outstanding, which increased from about 39.3 million to 60.8 million shares.
Impact
This financial update may have implications for various stakeholders, including investors, employees, and customers. Investors may view the growth in assets and loans as a positive sign of the bank's stability and potential for future profitability. Employees may feel more secure in their positions, while customers could benefit from enhanced services as the bank expands its operations.
What's Next
The filing does not specify the next steps for Farmers National Banc Corp. However, analysts and industry observers will likely keep a close watch on the bank's performance in the upcoming quarters, especially as it continues to adapt to the evolving financial landscape.
Source: SEC Accession Number 0001437749-26-035413
Read Next
Teradata reports Q3 results amid competitive software market
Under Armour reports quarterly results amid industry shifts
USBC, Inc. Reports Quarterly Results for Q3 2026
OneMedNet announces preliminary Q3 2026 financial results
Dogwood Therapeutics reports Q3 results amid industry shifts
Elanco Animal Health reports Q3 2026 financial results










